John W. M. Martens at Erasmus MC Cancer Institute University Medical Center Rotterdam The Netherlands - Research Interests, Publications & Academic Profile

John W. M. Martens

University Name

Netherlands

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

80%

Biostatistics

40%

Cancer Biology

100%

Dna Methylation

30%

Genomic Instability

30%

Genomic

30%

Mutagenesis

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

A Compendium of AR Splice Variants in Metastatic Castration-Resistant Prostate Cancer

Article Link

Year:

2023

mFast-SeqS-based aneuploidy score in circulating cell-free DNA is a prognostic biomarker in prostate cancer

Article Link

Year:

2023

Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling

Article Link

Year:

2023

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting

Article Link

Year:

2023

Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase

Article Link

Year:

2023

Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer

Article Link

Year:

2023

Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry

Article Link

Year:

2022

Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients

Article Link

Year:

2022

Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers

Article Link

Year:

2022

ESR1 Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients

Article Link

Year:

2022

Lost by Transcription: Fork Failures, Elevated Expression, and Clinical Consequences Related to Deletions in Metastatic Colorectal Cancer

Article Link

Year:

2022

Collaborators16

Gary Bader

Professor

University of Toronto

CANADA

Job van Riet

NETHERLANDS

Guido Jenster

Professor Experimental Urological Oncology

Erasmus MC

NETHERLANDS

Saskia Wilting

Erasmus University Rotterdam

NETHERLANDS

Reuben S. Harris

UNITED STATES

Esther de Hoop

Erasmus University Rotterdam

NETHERLANDS

Ruchi Bansal

University of Twente

NETHERLANDS

Bing-Jian Feng

Research Associate Professor

University of Utah

UNITED STATES

Leon W. M. M. Terstappen

NETHERLANDS

Ron Mathijssen

Erasmus University Rotterdam

NETHERLANDS

Jaco Kraan

Erasmus University Rotterdam

NETHERLANDS

Peter Devilee

Professor in Tumor Genetics, section leader

Leiden University Medical Center

NETHERLANDS

Corinna Ernst

University of Cologne

GERMANY

Anthony Mathelier

University of Oslo

NORWAY

Paul N. Span

Radboud University Medical Center

NETHERLANDS

Martijn Lolkema

Head of Department a.i.

Erasmus MC

NETHERLANDS

How do I reach out?

Meet Kite AI